Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 404 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/05/24
End: 11/30/28
Due: 11/30/29
Phase: N/A
Priority: Normal
Start: 02/26/24
End: 08/31/26
Due: 08/31/27
Phase: N/A
Priority: Normal
Start: 12/31/02
End: 12/31/07
Due: 12/31/08
Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer
Phase: N/A
Priority: Normal
Start: 11/01/18
End: 05/01/22
Due: 05/01/23
Phase: N/A
Priority: Normal
Start: 10/31/02
End: 06/30/08
Due: 06/30/09
Phase: N/A
Priority: Normal
Start: 08/17/21
End: 11/14/23
Due: 11/14/24
Phase: N/A
Priority: Normal
Start: 04/30/98
End: 06/30/02
Due: 06/30/03
Phase: N/A
Priority: Normal
Start: 12/22/22
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 04/12/17
End: 02/16/22
Due: 02/16/23
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 02/04/21
End: 11/01/24
Due: 11/01/25
Phase: N/A
Priority: Normal
Start: 08/31/90
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 12/31/04
End: 04/30/09
Due: 04/30/10
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 10/31/17
Due: 10/31/18
Phase: N/A
Priority: Normal
Start: 12/18/19
End: 08/31/22
Due: 08/31/23
Phase: N/A
Priority: Normal
Start: 07/17/19
End: 03/20/24
Due: 03/20/25
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 10/31/98
End: 11/30/00
Due: 11/30/01
Phase: N/A
Priority: Normal
Start: 08/31/05
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 02/14/20
End: 01/30/23
Due: 01/30/24
Phase: N/A
Priority: Normal
Start: 10/31/02
End: 10/31/04
Due: 10/31/05
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 07/31/16
Due: 07/31/17